FLT3 and cancer: As epitope spreading or antigen spreading is observed in autoimmune diseases or cancer research (15, 49–52) and FLT3 is only one of numerous antigens expressed on tumor cells, we also thought to test whether VRP vaccines could elicit antibody responses against antigens other than FLT3.